300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Sudan
Guernsey
Cameroon
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in United Kingdom (September 2026)

The most active venture capital funds investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Parkwalk Advisors
VC Fund
24 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $991k–$45M
Oxford Science Enterprises
VC Fund
16 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
UK Innovation & Science Seed Fund
VC Fund
16 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $482k–$14M
Future Planet Capital
VC Fund
13 United Kingdom, United States, Singapore Seed, Convertible Note Biotechnology, Health Care, Software $670k–$5.1M
SOSV
VC Fund
13 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Syncona Partners LLP
VC Fund
12 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.9M–$156M
Development Bank of Wales
VC Fund
11 United Kingdom, Australia, United States Seed, Debt Financing, Venture - Series Unknown Software, Health Care, Manufacturing $19k–$5.4M
24 Haymarket
VC Fund
11 United Kingdom, United States Venture - Series Unknown, Seed, Series A Health Care, Software, Biotechnology $107k–$16M
IQ Capital
VC Fund
11 United Kingdom, United States, Germany Seed, Series A Software, Artificial Intelligence, Machine Learning $1.3M–$40M
Sofinnova Partners
VC Fund
9 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
Selvedge Venture
VC Fund
9 United Kingdom, United States, Canada Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $1.1M–$30M
Angels in MedCity
VC Fund
8 United Kingdom, United States Seed, Angel Health Care, Biotechnology, Medical $313k–$2M
Newable Private Investing
VC Fund
8 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $196k–$5.6M
O2h Ventures
VC Fund
8 United Kingdom, Hungary Seed, Venture - Series Unknown, Series A Biotechnology, Health Care, Pharmaceutical $603k–$25M
Scottish Enterprise
VC Fund
8 United Kingdom, United States, Switzerland Grant, Seed, Venture - Series Unknown Biotechnology, Software, Health Care $119k–$9.4M
Maven Capital Partners
VC Fund
8 United Kingdom, United States, Germany Venture - Series Unknown, Seed, Private Equity Software, Information Technology, SaaS $648k–$15M
GM&C Life Sciences Fund
VC Fund
8 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $94k–$4.2M
Techstart Ventures
VC Fund
8 United Kingdom, Ireland, United States Seed, Pre-Seed Software, Information Technology, Health Care $197k–$4M
Google Ventures
VC Fund
7 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1.2M–$121M
Archangels
VC Fund
7 United Kingdom, United States Venture - Series Unknown, Seed Software, Health Care, Biotechnology $867k–$6.3M
Calculus Capital
VC Fund
7 United Kingdom, United States, Ireland Venture - Series Unknown, Series A Biotechnology, Software, Medical $1.9M–$10M
SR One
VC Fund
6 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6M–$175M
Kindred Capital
VC Fund
6 United Kingdom, United States, Germany Seed, Series A, Series B Software, Biotechnology, Health Care $1.4M–$73M
Scottish Investment Bank
VC Fund
6 United Kingdom, United States, France Venture - Series Unknown, Seed, Series A Software, Biotechnology, Health Care $245k–$7.9M
Amadeus Capital Partners
VC Fund
5 United Kingdom, United States, Spain Series A, Seed, Series B Software, Artificial Intelligence, Information Technology $800k–$56M
IP Group
VC Fund
5 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $438k–$30M
Northstar Ventures
VC Fund
5 United Kingdom, United States, Indonesia Seed, Venture - Series Unknown, Series A Software, Health Care, E-Commerce $39k–$10M
APEX Ventures
VC Fund
5 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $552k–$28M
Epidarex Capital
VC Fund
5 United Kingdom, United States, Germany Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $531k–$48M
Formic Ventures
VC Fund
5 United States, United Kingdom, Hong Kong Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $958k–$61M
Lima Ventures
VC Fund
5 Turkey, Estonia, United Kingdom Seed, Pre-Seed Artificial Intelligence, Software, FinTech $20k–$697k
Deepbridge Capital
VC Fund
5 United Kingdom, Spain, Australia Seed, Venture - Series Unknown, Series A Health Care, Biotechnology, Medical $142k–$15M
Antler
VC Fund
5 Singapore, Australia, United Kingdom Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
Verve Ventures
VC Fund
5 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $1.4M–$45M
Cambridge Innovation Capital
VC Fund
5 United Kingdom, United States, Ireland Series A, Series B, Seed Biotechnology, Health Care, Medical $2.5M–$73M
Octopus Ventures
VC Fund
4 United Kingdom, United States, Germany Series A, Seed, Series B Software, Artificial Intelligence, Health Care $2.2M–$44M
Ada Ventures
VC Fund
4 United Kingdom, Denmark, Ireland Seed, Pre-Seed Software, Artificial Intelligence, Health Care $507k–$8M
Catapult Ventures
VC Fund
4 United Kingdom, United States, Israel Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $150k–$5.6M
Episode 1
VC Fund
4 United Kingdom, United States, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $1M–$18M
Pentech Ventures
VC Fund
4 United Kingdom, United States, Ireland Series A, Series B Software, Information Technology, Analytics $1.3M–$60M
Brandon Capital
VC Fund
4 Australia, United Kingdom, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $673k–$81M
AlbionVC
VC Fund
4 United Kingdom, United States, France Series A, Seed Software, Information Technology, Health Care $2.4M–$19M
Martlet Capital
VC Fund
4 United Kingdom, United States Seed, Series A, Pre-Seed Health Care, Biotechnology, Software $193k–$9.5M
Dementia Discovery Fund
VC Fund
4 United States, United Kingdom, Israel Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Therapeutics $1.6M–$78M
Northern Gritstone
VC Fund
4 United Kingdom, Singapore Seed, Series A, Series D Software, Electronics, Health Care $2.4M–$229M
Acequia Capital (AceCap)
VC Fund
4 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$25M
Advent Life Sciences
VC Fund
4 United States, United Kingdom, France Series A, Series B Biotechnology, Health Care, Medical $5.5M–$105M
11.2 Capital
VC Fund
4 United States, Canada, United Kingdom Seed, Series A, Series B Software, Information Technology, Biotechnology $1M–$53M
SFC Capital
VC Fund
4 United Kingdom, United States, Canada Pre-Seed, Seed Artificial Intelligence, Software, Information Technology $131k–$2.2M
Playfair Capital
VC Fund
4 United Kingdom, United States, Switzerland Seed, Series A, Pre-Seed Software, Artificial Intelligence, Machine Learning $953k–$19M
Access all 703 VC funds in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 24 investments in United Kingdom Life Science startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 316
  • Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $2.2M–$45M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 16 investments in United Kingdom Life Science startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 202
  • Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $299M in 2022

Portfolio highlights

  • Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
  • Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 16 investments in United Kingdom Life Science startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 147
  • Round size: Seed $482k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
  • Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 13 investments in United Kingdom Life Science startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Singapore

Investor stats

  • Total investments: 264
  • Round size: Seed $670k–$5.1M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
  • Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 13 investments in United Kingdom Life Science startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Life Science startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 75
  • Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 11 investments in United Kingdom Life Science startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Debt Financing, Venture - Series Unknown
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 284
  • Round size: Seed $365k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.4M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
  • Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
  • MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 11 investments in United Kingdom Life Science startups

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 108
  • Round size: Seed $736k–$3.7M; Series A $1.6M–$16M; Venture - Series Unknown $107k–$4.6M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • WATR — WATR is the integrated system for real-time water or soil quality monitoring. Our products are robust, reliable, accurate, easy to use and benchmarked for accuracy.
  • pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
  • Previsico — Discover Previsico's real-time flood forecasting solutions, designed to mitigate risks for businesses and communities worldwide.
Show all investments...

IQ Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 11 investments in United Kingdom Life Science startups

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 213
  • Round size: Seed $1.3M–$12M; Series A $4.7M–$40M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
  • Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
  • Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 9 investments in United Kingdom Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 348
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Selvedge Venture
VC Fund · London, England, United Kingdom · 9 investments in United Kingdom Life Science startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 20
  • Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
  • MultiOmic Health — AI-Enabled Precision Medicine for Metabolic Syndrome
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 8 investments in United Kingdom Life Science startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $482k–$2M; Angel $313k–$1.2M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 8 investments in United Kingdom Life Science startups

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 106
  • Round size: Seed $196k–$3.1M; Series A $1.3M–$5.6M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Show all investments...

O2h Ventures
VC Fund · 8 investments in United Kingdom Life Science startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 60
  • Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 8 investments in United Kingdom Life Science startups, 34 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 389
  • Round size: Seed $387k–$4.3M; Grant $119k–$4.2M; Venture - Series Unknown $928k–$9.4M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
  • QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
  • Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Show all investments...

Maven Capital Partners
VC Fund · Glasgow, Glasgow City, United Kingdom · 8 investments in United Kingdom Life Science startups

Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Venture - Series Unknown, Seed, Private Equity
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 212
  • Round size: Seed $792k–$5M; Private Equity $981k–$15M; Venture - Series Unknown $648k–$8.1M
  • Lead/follow: 75% lead, 25% follow
  • Last fund: May invest from a new fund soon — raised $132M in 2019

Portfolio highlights

  • KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
  • Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
  • ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 8 investments in United Kingdom Life Science startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 36
  • Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Infex Therapeutics — Infex Therapeutics acquires, develops and licenses innovative drugs to treat pandemic infections
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 8 investments in United Kingdom Life Science startups, 6 in the past 12 months

Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 202
  • Round size: Seed $249k–$4M; Pre-Seed $197k–$1.3M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Go Swag — Branded gifts for people you work with
  • Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
  • Foresight — Foresight turns regulatory change into confident action. Compliance-critical teams see every change that affects their products across chemicals, sustainability, product safety, ESG, and HSE, with the evidence to act.
Show all investments...

Google Ventures
VC Fund · Mountain View, California, United States · 7 investments in United Kingdom Life Science startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 1425
  • Round size: Seed $1.2M–$16M; Series A $6M–$100M; Series B $16M–$121M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • Gusto — Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resources, and integration services for employers and employees in the United States.Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuterbenefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking, and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services.Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.
  • Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
  • OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 7 investments in United Kingdom Life Science startups

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 85
  • Round size: Seed $1.3M–$4.1M; Venture - Series Unknown $867k–$6.3M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
  • Bioliberty — Engineering the future of physical and occupational therapy.
  • Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Calculus Capital
VC Fund · London, England, United Kingdom · 7 investments in United Kingdom Life Science startups

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 80
  • Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.9M–$7.8M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
  • Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
  • Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 6 investments in United Kingdom Life Science startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 200
  • Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $237M in 2025

Portfolio highlights

  • CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 6 investments in United Kingdom Life Science startups, 10 in the past 12 months

A new model for Venture Capital where every founder we back becomes a co-owner of the fund.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 128
  • Round size: Seed $1.4M–$16M; Series A $7.9M–$33M; Series B $8M–$73M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fresh fund, raised $8M in 2026

Portfolio highlights

  • ZML — ZML is a production inference stack, purpose-built to decouple AI workloads from proprietary hardware.
  • Bios Life — Bios Life is a technology-enabled healthcare company built to empower individuals to proactively manage their cancer risk, redefining personalized cancer screening and survivorship.
  • Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 6 investments in United Kingdom Life Science startups

Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 270
  • Round size: Seed $331k–$3.1M; Series A $1.7M–$7.9M; Venture - Series Unknown $245k–$4.4M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in United Kingdom Life Science startups, 7 in the past 12 months

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 267
  • Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$56M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $85M in 2023

Portfolio highlights

  • Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
  • Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
  • Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 5 investments in United Kingdom Life Science startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 211
  • Round size: Seed $438k–$8.5M; Series A $2.4M–$30M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: Likely actively investing — fresh fund, raised $50M in 2026

Portfolio highlights

  • Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
  • Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
  • Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 5 investments in United Kingdom Life Science startups

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 215
  • Round size: Seed $39k–$2.1M; Series A $295k–$10M; Venture - Series Unknown $208k–$8.8M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $20M in 2024

Portfolio highlights

  • H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
  • NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
  • Advanced Electric Machines — Our magnet free motors help manufacturers build more sustainable vehicles and products. See how we can help you today.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 5 investments in United Kingdom Life Science startups

APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 61
  • Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 5 investments in United Kingdom Life Science startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 51
  • Round size: Seed $531k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$48M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $145M in 2026

Portfolio highlights

  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
  • Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 5 investments in United Kingdom Life Science startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 47
  • Round size: Seed $958k–$9M; Series A $17M–$61M; Venture - Series Unknown $2.4M–$3.1M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lima Ventures
VC Fund · Istanbul, Istanbul, Turkey · 5 investments in United Kingdom Life Science startups

Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, FinTech
  • Stage:Seed, Pre-Seed
  • Geography: Turkey, Estonia, United Kingdom

Investor stats

  • Total investments: 39
  • Round size: Seed $20k–$697k; Pre-Seed $50k–$100k
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
  • heybooster — heybooster is the creator of a platform for marketing analysis that aids e-commerce managers in finding chances for revenue growth and in making better choices. It provides clients with digital reporting, online meetings, online communication, an online project management system, and an online playbook that helps them discover problems, findpossibilities for revenue growth, and cut expenses.
  • Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 5 investments in United Kingdom Life Science startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Spain, Australia

Investor stats

  • Total investments: 91
  • Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
  • GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 5 investments in United Kingdom Life Science startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Singapore, Australia, United Kingdom

Investor stats

  • Total investments: 2372
  • Round size: Seed $158k–$4.5M; Pre-Seed $100k–$587k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026

Portfolio highlights

  • Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
  • Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
  • RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 5 investments in United Kingdom Life Science startups, 13 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 298
  • Round size: Seed $1.4M–$11M; Series A $2.1M–$18M; Series B $3.9M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $61M in 2022

Portfolio highlights

  • Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
  • Aylight — Aylight develops semiconductor laser and photonics platforms designed to improve optical connectivity in AI datacenters and related infrastructure. The company focuses on frequency modulated comb laser technology that generates multiple stable wavelengths from a single InP-based laser cavity. Its architecture produces an equidistant, RF-lockedwavelength grid that aligns with dense wavelength-division multiplexing requirements and reduces control complexity and power consumption. Aylight targets use cases in AI datacenter interconnects, quantum computing hardware, precision metrology, and communication equipment. Its products aim to integrate with terabit optical links and wavelength-division multiplexing systems while remaining compatible with existing fabrication processes.
  • Atana Elements — Atana is accelerating the exploration and development of flowing critical minerals and industrial gases. Atana uses a proprietary tech stack to identify and mature mineral resources quickly and effectively.
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 5 investments in United Kingdom Life Science startups

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 113
  • Round size: Seed $2.5M–$31M; Series A $2.6M–$73M; Series B $7.1M–$61M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $332M in 2025

Portfolio highlights

  • Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
  • Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 426
  • Round size: Seed $2.2M–$13M; Series A $3.3M–$22M; Series B $8M–$44M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — raised $108M in 2019

Portfolio highlights

  • geoSurge — Customers don't search. They ask.
  • Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
  • Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Show all investments...

Ada Ventures
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Ada Ventures is a pre-seed inclusive venture capital firm that invests in the best, not just the best-connected. They find and fund the Ada Lovelaces of today. Backing European founders building businesses for a better human future. They invest £250K - £1M in technology companies across climate equity, economic empowerment and healthy ageing. Adainvests in purpose-led founders building for markets that are large, untapped and growing. Their approach drives outperformance, which they call Inclusive Alpha®.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Denmark, Ireland

Investor stats

  • Total investments: 78
  • Round size: Seed $1.3M–$8M; Pre-Seed $507k–$1.4M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $81M in 2024

Portfolio highlights

  • Medly AI — Medly AI is a multilingual tutor that uses AI, theory of mind, and reinforcement learning technology to supercharge students' abilities. With Medly AI, students can engage in conversational learning, practice past exam questions, and get immediate marking and feedback. Medly AI also works with teachers to enhance the classroom, so thatstudents can have more personalized, inclusive learning experiences, and teachers can focus on what they do best - teaching.It was founded in 2023 in London, England, United Kingdom.
  • Boldr — Sustainability meets design. Save money and live more sustainably with Boldr products.
  • Interfaze — JigsawStack provides fine-tuned custom models that do the heavy lifting for APIs in every tech stack and helps ship faster.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 4 investments in United Kingdom Life Science startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 105
  • Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Show all investments...

Episode 1
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

We build relationships early, make decisions quickly, but engage with you for the long term. Our focus is getting B2B software companies at Pre-Seed and Seed to a successful Series A.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 168
  • Round size: Seed $1M–$5M; Pre-Seed $1M–$4M; Series A $5.1M–$18M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $96M in 2024

Portfolio highlights

  • RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
  • sable bio — We provide comprehensive, quantified, and flexible Target Safety Intelligence to assist toxicologists, informaticians, and drug discovery scientists in delivering safe and effective new treatments.
  • SimplyCook — SimplyCook offers home recipe kits with easy step-by-step guides to cook restaurant-quality food in less than 20 minutes.SimplyCook boxes contain 4 easy to follow recipes and 4 ingredient kits. Each kit is designed to provide perfect taste-containing ingredient blends devised by professional chefs.
Show all investments...

Pentech Ventures
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 4 investments in United Kingdom Life Science startups

Pentech Ventures is a venture capital fund focused on finding category defining software companies. Their passion is helping founders develop their startup into an internationally successful organisation. They have done this multiple times, partnering with leading VCs, corporations and investment banks along the way. They consider any opportunitycapable of becoming a market leader but are most comfortable being the first venture investor, supporting founders through the early stages of proving product and market fit. Their initial investment is likely to be £500K to £2M, with up to £10M invested over the lifetime of the investment.They invest in founders who are ambitious to build a global company, have the passion and ability to attract the best team and who are focused on the data and understand the key drivers in proving and building their business. They support the founders they invest in to develop and grow with their business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Analytics
  • Stage:Series A, Series B
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 81
  • Round size: Series A $1.3M–$17M; Series B $3.7M–$60M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $114M in 2017

Portfolio highlights

  • nPlan — AI that forecasts project outcomes, creates scenarios of the future and helps mitigate risk across single projects and portfolios. Trained on over 750,000 past programmes.
  • Causaly — Causaly is the fastest way to find evidence, explore hidden connections and make new predictions in biomedical science
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 4 investments in United Kingdom Life Science startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 83
  • Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely actively investing — fresh fund, raised $290M in 2025

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Lumonus — Hello, we are Lumonus! We empower oncology care teams through software solutions and services.
  • OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 179
  • Round size: Seed $2.4M–$12M; Series A $3.9M–$19M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • geoSurge — Customers don't search. They ask.
  • Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
  • Gravitee — Open Source API Management Platform - Gravitee
Show all investments...

Martlet Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 4 investments in United Kingdom Life Science startups

Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. Investing in the future.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 55
  • Round size: Seed $525k–$7.5M; Pre-Seed $193k–$1.2M; Series A $1M–$9.5M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
  • Infinitopes — Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinicaltrials, allowing patients to prevent cancer and tumors from taking their lives
  • AllFocal Optics — AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Show all investments...

Dementia Discovery Fund
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 56
  • Round size: Seed $4.8M–$20M; Series A $7M–$78M; Venture - Series Unknown $1.6M–$48M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fresh fund, raised $269M in 2025

Portfolio highlights

  • Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
  • Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Show all investments...

Northern Gritstone
VC Fund · Leeds, Leeds, United Kingdom · 4 investments in United Kingdom Life Science startups

Northern Gritstone is an investment firm focused on investing in advanced materials, energy, health technology and cognitive computation.

Show more...

Investment focus

  • Industry: Software, Electronics, Health Care
  • Stage:Seed, Series A, Series D
  • Geography: United Kingdom, Singapore

Investor stats

  • Total investments: 37
  • Round size: Seed $2.4M–$7.3M; Series A $2.5M–$27M; Series D $42M–$229M
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • AmpliSi —
  • Iceotope — Iceotope has developed technology with a blank drawing board and an open mind. So when we look at conventional problems, we find unconventional solutions.Built around our liquid-cooling approach and shaped by an extensive portfolio of patents, we’ve proven what our technology can do for HPC and data centre applications - dramatically reducingenergy consumption, space and noise. But it’s just the start. We’re going to keep innovating, working toward a day when wasteful, inefficient air-cooling is a thing of the past. We have created a business to look forward, but we’re also proud of the heritage that British engineering is built on. Iceotope is delighted to own the Made in Sheffield mark to show our dedication to the area’s tradition of engineering excellence. With decades of technical, design and engineering experience, we’ve established Iceotope as a trusted partner at the forefront of liquid-cooling technology. Now we’re investing to make sure we stay there: refining our designs, improving performance and engineering new applications.
  • Imperagen — Imperagen combines AI, QM/physics-based simulations, and high throughput lab testing to deliver true, verified enzyme improvements faster with lower cost.
Show all investments...

Acequia Capital (AceCap)
VC Fund · Seattle, Washington, United States · 4 investments in United Kingdom Life Science startups

We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 383
  • Round size: Seed $1.1M–$8M; Pre-Seed $500k–$3.3M; Series A $4.9M–$25M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely actively investing — fresh fund, raised $2.9M in 2026

Portfolio highlights

  • Rapidata — Fast and reliable data labeling that powers your AI. Define your label needs now and get the results in minutes.
  • Devplan — Devplan is an AI-powered workspace for product development teams, transforming ideas into execution-ready plans by integrating with tools like GitHub, Linear, Jira, and company docs.
  • Applied Atomics, Inc. — Powering the next 1,000 years of advanced industry with co-located nuclear power plants.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 70
  • Round size: Series A $5.5M–$51M; Series B $21M–$105M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

11.2 Capital
VC Fund · San Francisco, California, United States · 4 investments in United Kingdom Life Science startups

In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1M–$12M; Series A $7.3M–$26M; Series B $15M–$53M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Mantle — Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping.
  • CryptoNumerics — HIPAA, GDPR and Data Residency requirements restrict your ability to conduct data science. CryptoNumerics removes these restrictions. CryptoNumerics enables you to create privacy protected datasets with quantifiable privacy risk. In addition, you can build statistical and machine learning models that protect people’s privacy. Our team consists ofengineers and visionaries with previous experience in C-Level roles at Fortune 500 companies, founding teams of venture backed growth stage start-ups, and accomplished R&D leaders.
Show all investments...

SFC Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups, 60 in the past 12 months

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 578
  • Round size: Seed $131k–$2.2M; Pre-Seed $173k–$846k
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2019

Portfolio highlights

  • Keylr — Services partner for property managers. Book reliable, top-rated professionals for your properties with e-props.
  • Furbnow — Furbnow - Your companion for home improvements for the future
  • Checkboard — Complete your identity verification and payments without the paperwork. Checkboard handles your ID, open banking, and payments from one app.
Show all investments...

Playfair Capital
VC Fund · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups, 12 in the past 12 months

Playfair is a sector agnostic fund focused exclusively on pre-seed investing. Based in London, Playfair invests across the UK and Europe with an intentionally high conviction, low volume approach: making six investments a year out of its third $70m fund and preserving time, capital and resource to help companies post-investment. Our 78% Series Agraduation rate is ~3x industry average. Playfair has backed 100+ companies since 2013, including Thought Machine, Orca AI, Protex AI, StackOne and Nory.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 153
  • Round size: Seed $1.2M–$7.6M; Pre-Seed $953k–$3.1M; Series A $3M–$19M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely still investing — raised $70M in 2023

Portfolio highlights

  • Navifare — Navifare is an AI-powered travel price optimization and metasearch platform that focuses on flight, hotel, and car rental price comparison. The platform analyzes flight offers users already found and searches for lower fares from online travel agencies and airlines. Users can upload screenshots, paste flight details, or use a Chrome extension thatoverlays a “Find Better Fare” button on major booking sites. Navifare exposes its price discovery capabilities via a web app, a REST API, and an MCP server for integration into AI assistants. It redirects users to partner sites to complete bookings and does not handle payments directly.
  • Zerolook — Zerolook provides a flight-shopping API for online travel agencies, airlines, metasearch services, and AI travel applications. Its machine-learning model predicts flight prices and itineraries using historical fare data instead of recomputing every fare combination through a global distribution system or airline system. The API returns predicteditineraries, prices, and confidence scores for exploratory search, while customers route completed bookings through their existing distribution channels. Zerolook supports REST and MCP integrations and provides booking links to external airlines and online travel agencies.
  • Exclaim Robotics — Autonomous mobile robots for the AI data center.
Show all investments...

Life Science VC funding in United Kingdom at a glance

Stats across 683 deals from 703 investors.

703
investors
in United Kingdom Life Science startups
683
deals
in United Kingdom Life Science startups
$3.1M
median round
in United Kingdom Life Science startups
43%
lead investors
lead at least one round
25%
Seed
most common funding stage

Access all 703 VC funds in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 703 VC funds investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists